Pan Z K, Zuraw B L, Lung C C, Prossnitz E R, Browning D D, Ye R D
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
J Clin Invest. 1996 Nov 1;98(9):2042-9. doi: 10.1172/JCI119009.
Bradykinin (BK), a pluripotent nonameric peptide, is known for its proinflammatory functions in both tissue injury and allergic inflammation of the airway mucosa and submucosa. To understand the mechanisms by which BK serves as an inflammatory mediator, the human lung fibroblast cell line WI-38 was stimulated with BK and the expression of IL-1beta gene was examined. BK at nanomolar concentrations induced a marked increase in immunoreactive IL-1beta, detectable within 2 h in both secreted and cell-associated forms. BK-induced IL-1beta synthesis was inhibited by a B2-type BK receptor antagonist and by treatment of the cells with pertussis toxin, indicating the involvement of a BK receptor that couples to the G(i)/G(o) class of heterotrimeric G proteins. Whereas cycloheximide and actinomycin D both inhibited BK-induced IL-1beta synthesis, results from Northern blot and nuclear run-on assays suggested that BK acted primarily at the transcription level which led to the accumulation of IL-1beta message in stimulated cells. Gel mobility shift assays were used with nuclear extracts from stimulated WI-38 cells to examine the transcription mechanism for BK-induced IL-1beta expression. A DNA binding activity specific for the decameric kappaB enhancer was detected and was found to contain the p50 and p65 subunits of the NF-kappaB/rel protein family. BK-induced NF-kappaB activation correlated with IL-1beta message upregulation with respect to agonist concentration, time course, sensitivity to bacterial toxins, and blockade by the B2 receptor antagonist. After BK stimulation, a significant increase in the activity of chloramphenicol acetyltransferase was observed in WI-38 cells transfected with a reporter plasmid bearing the kappaB enhancers from the IL-1beta gene. Deletion of the kappaB enhancer sequence significantly reduced BK-induced chloramphenicol acetyltransferase activity. These findings suggests a novel function of BK in the activation of NF-kappaB and the induction of cytokine gene expression.
缓激肽(BK)是一种具有多种功能的九肽,因其在组织损伤以及气道黏膜和黏膜下层的过敏性炎症中发挥促炎作用而闻名。为了了解BK作为炎症介质的作用机制,用BK刺激人肺成纤维细胞系WI-38,并检测白细胞介素-1β(IL-1β)基因的表达。纳摩尔浓度的BK可诱导免疫反应性IL-1β显著增加,在2小时内即可在分泌形式和细胞相关形式中检测到。BK诱导的IL-1β合成受到B2型BK受体拮抗剂以及用百日咳毒素处理细胞的抑制,这表明涉及一种与异源三聚体G蛋白的G(i)/G(o)类偶联的BK受体。虽然放线菌酮和放线菌素D均抑制BK诱导的IL-1β合成,但Northern印迹和核转录分析结果表明,BK主要在转录水平起作用,从而导致受刺激细胞中IL-1β信使的积累。凝胶迁移率变动分析用于检测受刺激的WI-38细胞的核提取物,以研究BK诱导的IL-1β表达的转录机制。检测到一种对十聚体κB增强子具有特异性的DNA结合活性,并且发现其包含NF-κB/rel蛋白家族的p50和p65亚基。就激动剂浓度、时间进程、对细菌毒素的敏感性以及B2受体拮抗剂的阻断作用而言,BK诱导的NF-κB激活与IL-1β信使上调相关。BK刺激后,在用携带来自IL-1β基因的κB增强子的报告质粒转染的WI-38细胞中观察到氯霉素乙酰转移酶的活性显著增加。κB增强子序列的缺失显著降低了BK诱导的氯霉素乙酰转移酶活性。这些发现提示BK在激活NF-κB和诱导细胞因子基因表达方面具有新功能。